Jorgensen, J H <br/><br/>
Activities of newer fluoroquinolones against Streptococcus pneumoniae clinical isolates including those with mutations in the gyrA, parC, and parE loci.  [electronic resource] 

 -  Antimicrobial agents and chemotherapy  Feb 1999 
 - 329-34 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0066-4804 
<br/><br/><label>Standard No.: </label>10.1128/AAC.43.2.329  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anti-Infective Agents--pharmacology<br/>Bacterial Proteins--genetics<br/>DNA Gyrase<br/>DNA Topoisomerase IV<br/>DNA Topoisomerases, Type II--genetics<br/>DNA-Binding Proteins--genetics<br/>Drug Resistance, Microbial--genetics<br/>Humans<br/>Levofloxacin<br/>Microbial Sensitivity Tests<br/>Molecular Sequence Data<br/>Mutation<br/>Ofloxacin--pharmacology<br/>Streptococcus pneumoniae--drug effects